Answers are grounded in this paper and cite their sources.
To the Editor: Selective serotonin reuptake inhibitors (SSRIs) are currently considered first-line treatment for depression in the older people.1 Numerous spontaneous reports of syndrome of inappropriate secretion of antidiuretic hormone (SIADH) have followed their increased use, occurring most often in older people.2, 3 Recently, a retrospective study estimated the incidence of SSRI-induced SIADH to be as high as 12% in this population.4 We describe eight cases of SSRI-induced SIADH reported in our 304-bed university geriatric hospital between 1996 and 1997. Five cases were associated with citalopram and three with paroxetine. Hyponatremia precipitated hospitalization in four cases. All patients were women, with a median age of 86 years (range 78–89) and a median body mass index of 20 (range 16–27). Onset of SIADH was observed between 3 and 90 days after SSRI treatment. Prescribed doses were therapeutic (citalopram 10 to 30 mg, paroxetine 20 mg). One major paroxetine intoxication with a plasmatic concentration of 1176 ng/mL (normal range 70–150) was nonetheless observed. Hyponatremia was severe in six cases (natremia < 125 mmol/L), with a minimum value of 104 and a median plasmatic osmolality of 249 mmol/kg (229-261). Seventy-five percent of the patients had nausea, diarrhea, dizziness, and/or confusion. All patients were polymedicated (” four drugs concomitantly), and three were taking a diuretic. Two patients had pulmonary comorbidities (pulmonary fibrosis and bronchopneumonia). No patient had hypothyroidism. One death occurred, not related to SIADH (cardiorespiratory failure attributable to KCl intoxication). Hyponatremia resolved within 8 to 17 days in five patients after the SSRI was halted and fluid restriction instituted. No rechallenge was performed. Citalopram was continued under fluid restriction in two other patients with moderate hyponatremia. The hyponatremia resolved but reappeared when fluid restriction was removed. On the basis of our literature search (Medline 1966–1997), SSRI-induced SIADH seems not to be a rare phenomenon. We found 35 published cases with marked SSRIs, most of them in patients more than 70 years old. The chronology of clinical symptoms and laboratory data of our cases suggest a possible to probable imputability. As it was in two of our cases, it seems that moderate hyponatremia can be managed by fluid restriction alone. However, fluid restriction may be difficult for aged noninstitutionalized patients on a long-term basis. Risk of recurrence of hyponatremia after discharge from the hospital is probably high in these patients. Monitoring natremia is required in known SSRI-induced SIADH patients when the treatment is continued under fluid restriction. Age is probably not an independent factor in SSRI-induced SIADH, but other co-factors, such as pluripathology, polymedication, and/or malnutrition, may explain the higher incidence in this age group. Other prospective studies are now necessary to determine whether and how cofactors influence the onset and the severity of SSRI-induced hyponatremia.
No takes yet. Share an insight, caveat, or question.
Christe et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: